...虎城医生 rtal hypertension)、肝门静脉硬化症(hepatoportalsclerosis)、非硬化性门静脉纤维化(non-cirrhotic portal fibrosis，NCPF). 由于临床病理表现相似，很难明确区分，故目前认为是同一疾病，普遍接受的名称是IPH.
基于8个网页-相关网页
...医生 rtal hypertension)、肝门静脉硬化症(hepatoportalsclerosis)、非硬化性门静脉纤维化(non-cirrhotic portal fibrosis，NCPF). 由于临床病理表现相似，很难明确区分，故目前认为是同一疾病，普遍接受的名称是IPH.
基于3个网页-相关网页
非硬化性门静脉纤维化 non-cirrhotic portl fibrosis
目的探讨超声检测肝纤维化胆囊壁厚度与门静脉压力变化的关系。
Portal venous pressure and gallbladder wall thickness were measured by ultrasound on different stages of hepatic fibrosis.
结论经门静脉注射两种或两种以上供体活细胞可减轻慢性排斥反应，VEGF、ET-1的表达与血管硬化及纤维化程度呈正相关。
Conclusions Injection of two or more kinds of donor live cells may alleviate chronic rejection via decreasing of expressions of VEGF and ET-1 in the grafts.
动态观察门静脉主干及脾静脉宽度对了解患者肝纤维化和门脉高压程度有一定的临床意义。
Conclusions Dynamic observations on the widths of TPV and SPV have some significance to know degree of liver fibrosis and portal hypertension in patients with chronic viral hepatitis.
应用推荐